Apical regional wall motion abnormalities reminiscent to Tako-Tsubo cardiomyopathy following consumption of psychoactive fungi.
Holger M Nef, Helge Möllmann, Pirmin Hilpert, Nicola Krause, Christian Troidl, Michael Weber, Andreas Rolf, Thorsten Dill, Christian Hamm, A Elsässer
International journal of cardiology May 1, 2009 DOI: 10.1016/j.ijcard.2007.12.064 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | Young male patient |
| Duration | Several days |
| Citations | 24 |
| Key findings | Consumption of psychoactive fungi can trigger a reversible contractile dysfunction resembling Tako-Tsubo cardiomyopathy in the absence of coronary artery disease. |
Abstract
Consumption of natural hallucinogenic substances continues to be a problem. In this case we report from a young male patient presenting with an acute coronary syndrome with significant ST-elevation after the abuse of psychoactive fungi, commonly referred to as "magic mushrooms". Coronary angiography excludes relevant coronary artery disease. In ventriculography contractile dysfunction with hypokinesia in the apical segments could be documented reminiscent to wall motion abnormalities in Tako-Tsubo cardiomyopathy (TTC). Cardiovascular magnetic resonance imaging showed no pathological signal activity in the late-enhancement sequences ruling out myocardial infarction or inflammatory processes. Ventricular function normalized within several days. The active metabolite of psychoactive fungi psilocybin is known to interact with several different dopaminergic, adrenergic and serotonergic receptors. Thus, the pathomechanisms leading to contractile dysfunction after consumption of psychoactive fungi are reminiscent to those documented in TTC.
Citations in the library
Cited by 10
- Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol Therapeutic Drug Monitoring July 12, 2013
- Cardiovascular safety of psychedelic medicine: current status and future directions Pharmacological Reports October 24, 2023
- Psilocybin for the treatment of Alzheimer’s disease Frontiers in Neuroscience July 10, 2024
- Cardiovascular effects and safety of classic psychedelics. Nature cardiovascular research February 1, 2025
- Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer Journal of the Academy of Consultation-Liaison Psychiatry January 21, 2021
and 5 more in the library
Cites 3
- Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action Neuroreport December 1, 1998
- Psilocybin Mushroom (Psilocybe semilanceata) Intoxication with Myocardial Infarction Journal of Toxicology Clinical Toxicology 1998
- Dephosphorylation of Psilocybin to Psilocin by Alkaline Phosphatase Experimental Biology and Medicine 1961